CELG hit a strong resistance level after a 3-week momentum trend. This resistance is strong. The consolidation has Professional Trader footprints.
CELG completed a long-term bottoming formation in June and recently moved up to challenge a higher resistance level.
Celgene (CELG), Monthly chart: 4 years long mirror level + 2 Pin bars/"Shooting Stars" candle patterns.
Celgene Corp has had 3 HFT gaps this year. The first was gigantic. Then HFTs made a mistake and gapped the stock down. This resulted in Pro Trader buying at that lower level. Recently it gapped up and is in a compression mode.
I ran CELG in my earnings model using monthly data and it picked Dec 2018 as optimal buy point brschultz / markettimer777
I'm betting CELG breaks up :D. Nice risk/reward setup
The price right now is below to the support (danger!) but the week is not over. Maybe it's in phase 4 yet if the price close below to $77.41, or maybe actually we see here a phase 1 waiting for break the resistan.
$CELG Celgene long term chart looks to be in a clear downtrend. With a 50d/200d ema death cross on the weekly chart back in May and an inability to break through the 50d ema line in late August, (barring a significant earnings beat next week) I'm expecting this downtrend to continue into the final months of the year. Adding to the bearish sentiment, we saw some...
Celgene helped by the company's buyback has turned positive after a complicated year. Despite this in terms of foundamentals two drugs are on the way to be developped but such developments will be revealed in the next year so patient is a must for those who wants to invest of something concreate. On a technical point of view yesterday price faild to cross MA 200....
Weekly chart: we have the downtrend channel clearly defined on a weekly basis. On a monthly basis we have already had a minimum of swing with a dragon fly bullish, on a daily chart some signs of an incoming uptrend as described in the latest posts...but tomorrow...tomorrow is where we play the game with the last resistence in place at 86.72 dollars. Once we get...
Today and yesterday have the same exact high at 86.15, which makes that a tweezer top . CELG has made a nice recovery from the sell-off and looks to be holding the 100 day SMA on daily. If triggered in, I will look to close out before earnings on July 26 next week.
Bouncing off the 100SMA on the MONTHLY with a gorgeous Morning Star Reversal. I will be Buying 6 Month Call options down here. #buythesalsa
Celg is under the radar because after an insane downtrend, calm and a bit of optimism is getting back. Price is consolidating in a narrow range and on friday we have seen a first endeavour to break the flag with no success. This has happend because MA 50 has acted like a resistence. If the price breaks the wall of 80/80.50 with momentum I expect a new buy long...
Rules of Engagement Price is at a 200% extension of the previous swing on the Daily chart A 1-2-3 pattern has formed on the 1hr or 4hr chart ie. A prior swing high has been taken out by price action confirming our entry. Analysis Price at Daily support and order flow is forming a fractal. Sellers are taking profit and the Bulls are looking at an entry as price is...
What a tumultuous market. Celgene reports earnings on 5/4. Earnings play aside, are traders and investors rotating into or out of pharmaceuticals? The market doesn't know what to do with itself right now. With a Fed meeting taking place over the next couple days, Caterpillar's CFO claiming we've seen a "high water mark" with Q1 earnings, rate concerns,...
CELG - Inverse H+S / Cup and Handle - Possible breakout Note: Idea/opinion, not investment advise
CELG has pretty good analyst recommendations and it may present a good opportunity to buy at current price.
The former sees Celgene at $115 en route to filling the $109.25 gap. The latter sees Celgene test $121.70. Supporting the bear case: 1) Emerging broader market bearishness 2) Triple top on XBI daily + MACD bearish divergence 3) CELG weekly and daily charts turning lower + MACD bearish divergence + chinks in the quarterly fundamental story + persistent...